Unraveling the mechanisms involved in motor neuron degeneration in ALS

Annual Review of Neuroscience

Volumn 27, Issue , 2004, Pages 723-749

  Bruijn, Lucie I ^a   Miller, Timothy M ^b   Cleveland, Don W ^b  

^a ALS Association   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

Amyotrophic lateral sclerosis; Lou Gehrig's disease; Neurodegenerative; SOD1; Superoxide dismutase

Indexed keywords

CASPASE; CELECOXIB; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; EXCITOTOXIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; GROWTH FACTOR; MINOCYCLINE; NEUROTROPHIC FACTOR; PERIPHERIN; RILUZOLE; SOMATOMEDIN C; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; CATALYSIS; CELL DEATH; CLINICAL TRIAL; GENE MUTATION; GENE THERAPY; GENETIC ANALYSIS; HUMAN; HYPOTHESIS; INFLAMMATION; MICROGLIA; MITOCHONDRION; MODEL; MOTONEURON; MOTOR NEURON DISEASE; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; RETROGRADE NERVE FIBER TRANSPORT; REVIEW; TOXICITY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DYNEIN ATPASE; GLUTAMIC ACID; HUMANS; MODELS, NEUROLOGICAL; MOTOR NEURONS; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3943102116     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.27.070203.144244     Document Type: Review

References (159)

1. Abalkhail H, Mitchell J, Habgood J, Orrell R, de Belleroche J. 2003. A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. Am. J. Hum. Genet. 73:383-89
2. Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, et al. 1999. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 8:157-64
3. Al-Chalabi A, Scheffler MD, Smith BN, Parton MJ, Cudkowicz ME, et al. 2003. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis. Ann. Neurol. 54:130-34
4. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. 1994. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36:846-58
5. Alexianu ME, Kozovska M, Appel SH. 2001. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-89
6. Aimer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, et al. 2002. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 58:1277-79
7. Alvarez-Buylla A. 1992. Neurogenesis and plasticity in the CNS of adult birds. Exp. Neurol. 115:110-14
8. Alvarez-Buylla A, Garcia-Verdugo JM. 2002. Neurogenesis in adult subventricular zone. J. Neurosci. 22:629-34
9. Anand P, Parrett A, Martin J, Zeman S, Foley P, et al. 1995. Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat. Med. 1:168-72
10. Andersen PM. 2000. Genetic factors in the early diagnosis of ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 (Suppl. 1):S31-42
11. Andersen PM, Spitsyn VA, Makarov SV, Nilsson L, Kravchuk OI, et al. 2001. The geographical and ethnic distribution of the D90A CuZn-SOD mutation in the Russian Federation. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2:63-69
12. Anderson DJ, Gage FH, Weissman IL. 2001. Can stem cells cross lineage boundaries? Nat. Med. 7:393-95
13. Andreassen OA, Ferrante RJ, Klivenyi P, Klein AM, Shinobu LA, et al. 2000. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis. Ann. Neurol. 47:447-55
14. Andrus PK, Fleck TJ, Gurney ME, Hall ED. 1998. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71:2041-48
15. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. 1997. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:644-54
16. Beaulieu JM, Nguyen MD, Julien JP. 1999. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147:531-44
17. Beckman JS, Carson M, Smith CD, Koppenol WH. 1993. ALS, SOD and peroxynitrite. Nature 364:584
18. Beckman JS, Chen J, Crow JP, Ye YZ. 1994. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog. Brain Res. 103:371-80
19. Blaauwgeers HG, Anwar Chand M, van den Berg FM, Vianney de Jong JM, Troost D. 1996. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 142:39-44
20. Blair JP, Bennett CL, Abel A, Rabin BA, Griffin JW, et al. 2000. A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. Neurogenetics 3:1-6
21. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, et al. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91:8292-96
22. Bowling AC, Barkowski EE, McKenna-Yasek D, Sapp P, Horvitz HR, et al. 1995. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J. Neurochem. 64:2366-69
23. Brazelton TR, Rossi FM, Keshet GI, Blau HM. 2000. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775-79
24. Bruening W, Roy J, Giasson B, Figlewicz DA, Mushynski WE, Durham HD. 1999. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 72:693-99
25. Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, et al. 1997a. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 94:7606-11
26. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, et al. 1997b. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-38
27. Bruijn LI, Cleveland DW. 1996. Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease. Neuropathol. Appl. Neurobiol. 22:373-87
28. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, et al. 1998. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851-54
29. Bush AI. 2002. Is ALS caused by an altered oxidative activity of mutant superoxide dismutase? Nat. Neurosci. 5:919
30. Carpenter S. 1968. Proximal axonal enlargement in motor neuron disease. Neurology 18:841-51
31. Chou SM, Fakadej AV. 1971. Ultrastructure of chromatolytic motoneurons and anterior spinal roots in a case of Werdnig-Hoffmann disease. J. Neuropathol. Exp. Neurol. 30:368-79
32. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, et al. 2000. Generalized potential of adult neural stem cells. Science 288:1660-63
33. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, et al. 2003. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-17
34. Corbo M, Hays AP. 1992. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51:531-37
35. Corson LB, Strain JJ, Culotta VC, Cleveland DW. 1998. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. USA 95: 6361-66
36. Couillard-Despres S, Zhu Q, Wong PC, Price DL, Cleveland DW, Julien JP. 1998. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA 95:9626-30
37. Culotta VC, Klomp LW, Strain J, Casareno RL, Krems B, Gitlin JD. 1997. The copper chaperone for superoxide dismutase. J. Biol. Chem. 272:23469-72
38. Dal Canto MC, Gurney ME. 1994. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145:1271-79
39. Dawson TM. 2000. New animal models for Parkinson's disease. Cell 101:115-18
40. De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, et al. 2001. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 49:245-49
41. Delisle MB, Carpenter S. 1984. Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J. Neurol. Sci. 63:241-50
42. Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, et al. 2003. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2:209-17
43. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Aimer G, et al. 2002. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52:771-78
44. Elliott JL. 2001. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95:172-78
45. Elliott JL, Snider WD. 1996. Motor neuron growth factors. Neurology 47:S47-53
46. Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, et al. 1999. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286:2498-500
47. Field LS, Furukawa Y, O'Halloran TV, Culotta VC. 2003. Factors controlling the uptake of yeast copper/zinc superoxide dismutase into mitochondria. J. Biol. Chem. 278:28052-59
48. Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, et al. 1994. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3:1757-61
49. Gage FH. 2002. Neurogenesis in the adult brain. J. Neurosci. 22:612-13
50. Garcia ML, Lobsiger CS, Shah SB, Deerinck TJ, Crum J, et al. 2003. NF-M is an essential target for the mylein-directed "outside-in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 163:1011-20
51. Gaudette M, Hirano M, Siddique T. 2000. Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1:83-89
52. Giess R, Holtmann B, Braga M, Grimm T, Muller-Myhsok B, et al. 2002. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. Am. J. Hum. Genet. 70:1277-86
53. Gonatas NK, Stieber A, Mourelatos Z, Chen Y, Gonatas JO, et al. 1992. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am. J. Pathol. 140:731-37
54. Gong YH, Elliott JL. 2000. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Exp. Neurol. 162:27-36
55. Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL. 2000. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20:660-65
56. Goodell MA, Jackson KA, Majka SM, Mi T, Wang H, et al. 2001. Stem cell plasticity in muscle and bone marrow. Ann. NY Acad. Sci. 938:208-18
57. Guegan C, Vila M, Rosoklija G, Hays AP, Przedborski S. 2001. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21:6569-76
58. Gurney ME. 1994. Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 331:1721-22
59. Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, et al. 2001. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29:166-73
60. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, et al. 2003. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300:808-12
61. Haley RW 2003. Excess incidence of ALS in young Gulf War veterans. Neurology 61: 750-56
62. Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME. 1998. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J. Neurosci. Res. 53:66-77
63. Hand CK, Khoris J, Salachas F, Gros-Louis F, Lopes AA, et al. 2002. A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am. J. Hum. Genet. 70:251-56
64. Hanisch UK. 2002. Microglia as a source and target of cytokines. Glia 40:140-55
65. Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, et al. 2002. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82:365-74
66. Hentati A, Ouahchi K, Pericak-Vance MA, Nijhawan D, Ahmad A, et al. 1998. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 2:55-60
67. Higgins CM, Jung C, Ding H, Xu Z. 2002. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci. 22:RC215
68. Hirano A. 1991. Cytopathology of amyotrophic lateral sclerosis. Adv. Neurol. 56:91-101
69. Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G. 1984. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43:471-80
70. Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, et al. 2003. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 61:742-49
71. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, et al. 2000. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 284:1664-69
72. Rowland DS, Liu J, She Y, Goad B, Maragakis NJ, et al. 2002. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 99:1604-9
73. Ince P, Stout N, Shaw P, Slade J, Hunziker W, et al. 1993. Parvalbumin and calbindinD-28k in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol. 19:291-99
74. Ince PG, Shaw PJ, Slade JY, Jones C, Hudgson P. 1996. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. (Berlin) 92:395-403
75. Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, et al. 2000. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7:623-43
76. Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC. 2001. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. (Berlin) 102:293-305
77. Jacob C, Maret W, Vallee BL. 1998. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. USA 95:3489-94
78. Johnston JA, Dalton MJ, Gurney ME, Kopito RR. 2000. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97:12571-76
79. Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, et al. 2004. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 127:73-88
80. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. 2003. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839-42
81. Kato S, Takikawa M, Nakashima K, Hirano A, Cleveland DW, et al. 2000. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1:163-84
82. Kawamata T, Akiyama H, Yamada T, McGeer PL. 1992. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140:691-707
83. Kawamura Y, Dyck PJ, Shimono M, Okazaki H, Tateishi J, Doi H. 1981. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol. Exp. Neurol. 40:667-75
84. King SJ, Schroer TA. 2000. Dynactin increases the processivity of the cytoplasmic dynein motor. Nat. Cell Biol. 2:20-24
85. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, et al. 1999. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5:347-50
86. Kong J, Xu Z. 1998. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18:3241-50
87. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. 1997. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277:559-62
88. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312-18
89. Kriz J, Nguyen MD, Julien JP. 2002. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 10:268-78
90. Kunst CB, Messer L, Gordon J, Haines J, Patterson D. 2000. Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics 70:181-89
91. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, et al. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34:383-94
92. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, et al. 2002. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34:715-27
93. Lariviere RC, Beaulieu JM, Nguyen MD, Julien JP. 2003. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Neurobiol. Dis. 13:158-66
94. Lee MK, Cleveland DW 1996. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19:187-217
95. Leigh PN, Swash M. 1991. Cytoskeletal pathology in motor neuron diseases. Adv. Neurol. 56:115-24
96. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, et al. 1991. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114:775-88
97. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, et al. 2000. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288:335-39
98. Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, et al. 1998. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20:589-602
99. Lino MM, Schneider C, Caroni P. 2002. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22:4825-32
100. Liochev SI, Fridovich I. 2000. Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase. J. Biol. Chem. 275:38482-85
101. Liu H, Zhu H, Eggers DK, Nersissian AM, Faull KF, et al. 2000. Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant. Biochemistry 39:8125-32
102. Magavi SS, Macklis JD. 2001. Manipulation of neural precursors in situ: induction of neurogenesis in the neocortex of adult mice. Neuropsychopharmacology 25:816-35
103. Mather K, Martin JE, Swash M, Vowles G, Brown A, Leigh PN. 1993. Histochemical and immunocytochemical study of ubiquitinated neuronal inclusions in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 19:141-45
104. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, et al. 2002. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277:29626-33
105. McGeer EG, McGeer PL. 1999. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharm. Des. 5:821-36
106. Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, et al. 2000. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67:37-46
107. Mulder DW, Kurland LT. 1987. Motor neuron disease: epidemiologic studies. Adv. Exp. Med. Biol. 209:325-32
108. Mulder DW, Kurland LT, Offord KP, Beard CM. 1986. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36:511-17
109. Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, et al. 2001. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21:9246-54
110. Nagano S, Satoh M, Sumi H, Fujimura H, Tohyama C, et al. 2001. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur. J. Neurosci. 13:1363-70
111. Nguyen MD, Julien JP, Rivest S. 2001a. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann. Neurol. 50:630-39
112. Nguyen MD, Lariviere RC, Julien JP. 2001b. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135-47
113. Niwa J, Ishigaki S, Hishikawa N, Yamamoto M, Doyu M, et al. 2002. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J. Biol. Chem. 277:36793-98
114. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, et al. 2001. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:131-38
115. Oppenheim RW. 1996. Neurotrophic survival molecules for motoneurons: an embarrassment of riches. Neuron 17:195-97
116. Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, et al. 2003. ALS2, a novel guanine nucleotide exchange factor for the small GT-Pase Rab5, is implicated in endosomal dynamics. Hum. Mol. Genet. 12:1671-87
117. Palmiter RD. 1998. The elusive function of metallothioneins. Proc. Natl. Acad. Sci. USA 95:8428-30
118. Pasinelli P, Houseweart MK, Brown RH, Jr., Cleveland DW. 2000. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97:13901-6
119. Pramatarova A, Laganiere J, Roussel J, Brisbois K, Rouleau GA. 2001. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21:3369-74
120. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, et al. 2003. Mutant dynactin in motorneuron disease. Nat. Genet. 33:455-56
121. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV. 1999. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284:805-8
122. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, et al. 2002. Motoneuron death triggered by a specific pathway downstream of Fas: potentiation by ALS-linked SOD1 mutations. Neuron 35:1067-83
123. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, et al. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:43-47
124. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. 1995. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92:689-93
125. Robertson J, Doroudchi MM, Nguyen MD, Durham HD, Strong MJ, et al. 2003. A neurotoxic peripherin splice variant in a mouse model of ALS. J. Cell Biol. 160:939-49
126. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
127. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, et al. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-86
128. Rothstein JD, Kuncl R, Chaudhry V, Clawson L, Cornblath DR, et al. 1991. Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann. Neurol. 30:224-25
129. Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, et al. 1990. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28:18-25
130. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. 1995. S elective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:73-84
131. Ruddy DM, Parton MJ, Al-Chalabi A, Lewis CM, Vance C, et al. 2003. Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am. J. Hum. Genet. 73:390-96
132. Sapp PC, Hosler BA, McKenna-Yasek D, Chin W, Gann A, et al. 2003. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 73:397-403
133. Selkoe DJ. 2001. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98:11039-41
134. Shaw PJ, Forrest V, Ince PG, Richardson JP, Wastell HJ. 1995. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4:209-16
135. Shibata N, Asayama K, Hirano A, Kobayashi M. 1996. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev. Neurosci. 18:492-98
136. Shinder GA, Lacourse MC, Minotti S, Durham HD. 2001. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276:12791-96
137. Son M, Fathallah-Shaykh HM, Elliott JL. 2001. Survival in atransgenic model of FALS is independent of iNOS expression. Ann. Neurol. 50:273
138. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, et al. 2001. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739-43
139. Subramaniam JR, Lyons WE, Liu J, Bartnikas TB, Rothstein J, et al. 2002. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5:301-7
140. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J, Deguchi T. 1994. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 7:79-84
141. Takeuchi H, Kobayashi Y, Ishigaki S, Doyu M, Sobue G. 2002. Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 277:50966-72
142. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, et al. 1997. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-702
143. Tomkins J, Usher P, Slade JY, Ince PG, Curtis A, et al. 1998. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). NeuroReport 9:3967-70
144. Trotti D, Aoki M, Pasinelli P, Berger UV, Danbolt NC, et al. 2001. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J. Biol. Chem. 276:576-82
145. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W. 2002. Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport 13:1067-70
146. Vukosavic S, Stefanis L, Jackson-Lewis V, Guegan C, Romero N, et al. 2000. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 20:9119-25
147. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, et al. 2003. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 12:2753-64
148. Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, et al. 2002. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol. Dis. 10:128-38
149. Wichterle H, Lieberam I, Porter JA, Jessell TM. 2002. Directed differentiation of embryonic stem cells into motor neurons. Cell 110:385-97
150. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, et al. 1996. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271:515-18
151. Wilhelmsen KC. 1997. Disinhibition-dementia-parkinsonism-amyotrophy complex (DDPAC) is a non-Alzheimer's frontotemporal dementia. J. Neural Transm. Suppl. 49:269-75
152. Williamson TL, Bruijn LI, Zhu Q, Anderson KL, Anderson SD, et al. 1998. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 95:9631-36
153. Williamson TL, Corson LB, Huang L, Burlingame A, Liu J, et al. 2000. Toxicity of ALS-linked SOD1 mutants. Science 288:399
154. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, et al. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-16
155. Wong PC, Waggoner D, Subramaniam JR, Tessarollo L, Bartnikas TB, et al. 2000. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 97:2886-91
156. Yamanaka K, Vande Velde C, Bertini E, Boespflug-Tanguy O, Cleveland DW. 2003. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early onset motor neuron disease. Proc. Natl. Acad. Sci. 100:16041-46
157. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, et al. 2001. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29:160-65
158. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. USA 96:13496-500
159. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, et al. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78